Company / Operating Cash Flow per Share
KYNTRA BIO, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$34.18
FY2025
5-year range
-$34.18 / $0.88
FY2021-FY2025
Trend
-971.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -972% YoY in FY2025, a notable deviation from the 9-year average annual change of -256%.
Based on SEC 10-K filings.
-34.18 in FY2025.
Declined from $-0.87 to $-34.18 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- KYNTRA BIO, INC.'s operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 971.8% year-over-year.
- Peak operating cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$34.18 | -971.8% |
| FY2024 | -$3.19 | -265.2% |
| FY2023 | -$0.87 | -199.4% |
| FY2022 | $0.88 | +202.1% |
| FY2021 | -$0.86 | +0.9% |
| FY2020 | -$0.87 | -11.6% |
| FY2019 | -$0.78 | -1003.6% |
| FY2018 | $0.09 | +129.5% |
| FY2017 | -$0.29 | -180.7% |
| FY2016 | $0.36 | -17.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026